Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - Intel stock falls after Nvidia reduces its stake by 25%

BUZZ - Intel stock falls after Nvidia reduces its stake by 25%

路透社路透社2026/11/16 22:22
Show original

- ** Intel (INTC.O) shares fell 3.6% in after-hours trading, closing at $53.51

** According to documents from the U.S. Securities and Exchange Commission (SEC), Nvidia NVDA.O reduced its stake in Intel (link) by 25% from the previous quarter to 161.1 million shares as of September 30

** NVDA also reduced its holdings in Nokia NOKIA.HE and Synopsys SNPS.O, while increasing its holdings in SpaceX SPCX.O

** As of Monday’s close, Intel (INTC) had gained approximately 50% so far this year



(To facilitate non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential inaccuracies or lack of necessary context in automated translations, Reuters does not guarantee the accuracy of these texts and provides them solely for readers’ convenience. Reuters assumes no responsibility for any damage or loss arising from the use of automated translation functions.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Deutsche Bank believes that the continuously expanding chip trade surplus in Asia is becoming a supporting force for the US dollar, as related profits are increasingly being reinvested into the US stock market.

智通财经•2026/11/16 23:03
The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Roche's (RHHBY.US) new breast cancer drug Wilserdly approved by FDA: Analysts predict peak annual sales could reach up to $14.5 billion

Roche's (RHHBY.US) new oral breast cancer drug has been approved by U.S. regulators, paving the way for this medication, which the pharmaceutical company hopes will transform the treatment of the disease.

智通财经•2026/11/16 22:53

Soros Family Office Leads in Reducing Nvidia Holdings, Top Billionaires Cashed Out Quietly Before Jensen Huang's Departure

Several ultra-high-net-worth family offices collectively reduced their holdings in Nvidia during Q3, including the Soros Family Office, BlueCrest, and Abu Dhabi sovereign investment institutions. This move secured profits just before CEO Jensen Huang was dismissed by the board on November 12 due to an extramarital affair scandal. More than ten institutions participated in the reduction, although all retained some holdings, with the combined market value of their shares still exceeding $1 billion. Meanwhile, some institutions continued to increase their positions against the trend.

华尔街见闻•2026/11/16 22:41